Cristina Gay

Dr. Cristina Gay

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2023 in Medicina Clínica (English Edition)
Verified
Journal Article
Closed access
RBRamón Baeza-Trinidad
Ramón Baeza-Trinidad
LRLuis Rosel-Rioja
Luis Rosel-Rioja
YBYasmina Brito-Diaz
Yasmina Brito-Diaz
CGCristina Gay
Cristina Gay

16 February 2023 in Medicina Clinica
Verified
Journal Article
Closed access
RBRamón Baeza-Trinidad
Ramón Baeza-Trinidad
LRLuis Rosel-Rioja
Luis Rosel-Rioja
YBYasmina Brito-Diaz
Yasmina Brito-Diaz
CGCristina Gay
Cristina Gay

12 June 2026 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
CGCristina Gay
Cristina Gay
IGIrati Arregui García
Irati Arregui García
JCJimmy Alonso Madrigal Cruz
Jimmy Alonso Madrigal Cruz
JBJose-Ramon Blanco
Jose-Ramon Blanco

11 June 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
CGCristina Gay
Cristina Gay
LMLucia Ramos Merino
Lucia Ramos Merino
ESElena Sandoval
Elena Sandoval
DMDavid Couto Mallon
David Couto Mallon
APAndres Perissinottti
Andres Perissinottti
MCMaría G. Crespo-Lerio
María G. Crespo-Lerio
Background: Infections remain a major complication in patients with left ventricular assist devices (LVADs). Enterococcal infections are increasingly recognized and are therapeutically challenging because of antimicrobial tolerance, biofilm formation on prosthetic material, and the frequent impossibility of device removal. Objective and method: We report two clinical cases of Enterococcus faecalis LVAD infection and a PRISMA-based systematic review of cases published between 1996 and 2025 that were identified through PubMed/MEDLINE. Primary outcomes were clinical cure, relapse or recurrence, mortality, and device removal. Results were synthesized descriptively. Results: Seventeen cases were analyzed, including 15 previously reported cases and two new cases. E. faecalis accounted for 47% of infections, Enterococcus faecium for 29%, and Enterococcus spp. without species identification for 24%. Bacteremia was the most common presentation, occurring in 76%, whereas LVAD-associated endocarditis occurred in 18%. Driveline or pocket involvement was reported in 41%. Suppressive antimicrobial therapy (SAT) was used in 29%, often as a bridge to heart transplantation. Cultures from explanted LVAD components were positive in 47% of cases despite prolonged antimicrobial therapy. Recurrence or relapse and overall mortality each occurred in 18% of patients. Conclusions: Enterococcal LVAD infections may be associated with microbiological persistence despite prolonged therapy. SAT may help control infection in selected patients and bridge to heart transplantation when device removal is not feasible.